vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and Shutterstock, Inc. (SSTK). Click either name above to swap in a different company.

Shutterstock, Inc. is the larger business by last-quarter revenue ($220.2M vs $121.8M, roughly 1.8× Core Laboratories Inc.). Core Laboratories Inc. runs the higher net margin — 4.2% vs -7.3%, a 11.5% gap on every dollar of revenue. On growth, Core Laboratories Inc. posted the faster year-over-year revenue change (-1.4% vs -12.0%). Shutterstock, Inc. produced more free cash flow last quarter ($25.9M vs $517.0K). Over the past eight quarters, Shutterstock, Inc.'s revenue compounded faster (1.4% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Shutterstock, Inc. is an American provider of stock photography, stock footage, stock music, and editing tools; it is headquartered in New York. Founded in 2002 by programmer and photographer Jon Oringer, Shutterstock maintains a library of around 200 million royalty-free stock photos, vector graphics, and illustrations, with around 10 million video clips and music tracks available for licensing. Originally a subscription site only, Shutterstock expanded beyond subscriptions into à la carte p...

CLB vs SSTK — Head-to-Head

Bigger by revenue
SSTK
SSTK
1.8× larger
SSTK
$220.2M
$121.8M
CLB
Growing faster (revenue YoY)
CLB
CLB
+10.6% gap
CLB
-1.4%
-12.0%
SSTK
Higher net margin
CLB
CLB
11.5% more per $
CLB
4.2%
-7.3%
SSTK
More free cash flow
SSTK
SSTK
$25.4M more FCF
SSTK
$25.9M
$517.0K
CLB
Faster 2-yr revenue CAGR
SSTK
SSTK
Annualised
SSTK
1.4%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLB
CLB
SSTK
SSTK
Revenue
$121.8M
$220.2M
Net Profit
$5.1M
$-16.0M
Gross Margin
55.8%
Operating Margin
1.5%
-1.1%
Net Margin
4.2%
-7.3%
Revenue YoY
-1.4%
-12.0%
Net Profit YoY
-1021.0%
EPS (diluted)
$0.11
$-0.47

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
SSTK
SSTK
Q1 26
$121.8M
Q4 25
$138.3M
$220.2M
Q3 25
$134.5M
$260.1M
Q2 25
$130.2M
$267.0M
Q1 25
$123.6M
$242.6M
Q4 24
$129.2M
$250.3M
Q3 24
$134.4M
$250.6M
Q2 24
$130.6M
$220.1M
Net Profit
CLB
CLB
SSTK
SSTK
Q1 26
$5.1M
Q4 25
$4.9M
$-16.0M
Q3 25
$14.2M
$13.4M
Q2 25
$10.6M
$29.4M
Q1 25
$-154.0K
$18.7M
Q4 24
$7.4M
$-1.4M
Q3 24
$11.7M
$17.6M
Q2 24
$9.0M
$3.6M
Gross Margin
CLB
CLB
SSTK
SSTK
Q1 26
Q4 25
20.8%
55.8%
Q3 25
22.0%
60.6%
Q2 25
20.3%
60.3%
Q1 25
19.5%
58.4%
Q4 24
17.8%
55.1%
Q3 24
20.5%
58.3%
Q2 24
21.2%
58.5%
Operating Margin
CLB
CLB
SSTK
SSTK
Q1 26
1.5%
Q4 25
11.5%
-1.1%
Q3 25
15.6%
12.5%
Q2 25
11.7%
13.0%
Q1 25
3.6%
4.2%
Q4 24
11.0%
5.3%
Q3 24
14.7%
7.2%
Q2 24
12.3%
9.4%
Net Margin
CLB
CLB
SSTK
SSTK
Q1 26
4.2%
Q4 25
3.6%
-7.3%
Q3 25
10.6%
5.1%
Q2 25
8.2%
11.0%
Q1 25
-0.1%
7.7%
Q4 24
5.7%
-0.6%
Q3 24
8.7%
7.0%
Q2 24
6.9%
1.6%
EPS (diluted)
CLB
CLB
SSTK
SSTK
Q1 26
$0.11
Q4 25
$0.11
$-0.47
Q3 25
$0.30
$0.37
Q2 25
$0.22
$0.82
Q1 25
$0.00
$0.53
Q4 24
$0.15
$-0.04
Q3 24
$0.25
$0.50
Q2 24
$0.19
$0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
SSTK
SSTK
Cash + ST InvestmentsLiquidity on hand
$22.8M
$178.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$275.1M
$581.0M
Total Assets
$587.7M
$1.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
SSTK
SSTK
Q1 26
$22.8M
Q4 25
$22.7M
$178.2M
Q3 25
$25.6M
$165.5M
Q2 25
$31.2M
$116.4M
Q1 25
$22.1M
$112.2M
Q4 24
$19.2M
$111.3M
Q3 24
$21.5M
$131.4M
Q2 24
$17.7M
$74.9M
Total Debt
CLB
CLB
SSTK
SSTK
Q1 26
Q4 25
$110.3M
Q3 25
$114.1M
Q2 25
$124.6M
Q1 25
$124.4M
Q4 24
$126.1M
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
CLB
CLB
SSTK
SSTK
Q1 26
$275.1M
Q4 25
$266.0M
$581.0M
Q3 25
$271.3M
$594.4M
Q2 25
$261.3M
$586.2M
Q1 25
$253.4M
$547.2M
Q4 24
$246.6M
$518.4M
Q3 24
$250.7M
$522.9M
Q2 24
$240.3M
$520.4M
Total Assets
CLB
CLB
SSTK
SSTK
Q1 26
$587.7M
Q4 25
$584.0M
$1.4B
Q3 25
$591.4M
$1.4B
Q2 25
$602.1M
$1.4B
Q1 25
$591.5M
$1.3B
Q4 24
$585.1M
$1.3B
Q3 24
$600.5M
$1.3B
Q2 24
$597.8M
$1.0B
Debt / Equity
CLB
CLB
SSTK
SSTK
Q1 26
Q4 25
0.41×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
SSTK
SSTK
Operating Cash FlowLast quarter
$4.0M
$36.2M
Free Cash FlowOCF − Capex
$517.0K
$25.9M
FCF MarginFCF / Revenue
0.4%
11.8%
Capex IntensityCapex / Revenue
4.7%
Cash ConversionOCF / Net Profit
0.77×
TTM Free Cash FlowTrailing 4 quarters
$22.5M
$123.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
SSTK
SSTK
Q1 26
$4.0M
Q4 25
$7.9M
$36.2M
Q3 25
$8.5M
$78.4M
Q2 25
$13.9M
$26.8M
Q1 25
$6.7M
$25.2M
Q4 24
$20.6M
$8.0M
Q3 24
$13.1M
$-11.6M
Q2 24
$17.1M
$28.0M
Free Cash Flow
CLB
CLB
SSTK
SSTK
Q1 26
$517.0K
Q4 25
$5.0M
$25.9M
Q3 25
$6.5M
$68.0M
Q2 25
$10.4M
$15.5M
Q1 25
$3.9M
$14.4M
Q4 24
$17.4M
$-952.0K
Q3 24
$10.4M
$-26.3M
Q2 24
$14.3M
$18.9M
FCF Margin
CLB
CLB
SSTK
SSTK
Q1 26
0.4%
Q4 25
3.6%
11.8%
Q3 25
4.8%
26.1%
Q2 25
8.0%
5.8%
Q1 25
3.1%
6.0%
Q4 24
13.4%
-0.4%
Q3 24
7.7%
-10.5%
Q2 24
10.9%
8.6%
Capex Intensity
CLB
CLB
SSTK
SSTK
Q1 26
Q4 25
2.1%
4.7%
Q3 25
1.5%
4.0%
Q2 25
2.7%
4.2%
Q1 25
2.3%
4.5%
Q4 24
2.5%
3.6%
Q3 24
2.0%
5.9%
Q2 24
2.2%
4.1%
Cash Conversion
CLB
CLB
SSTK
SSTK
Q1 26
0.77×
Q4 25
1.61×
Q3 25
0.60×
5.86×
Q2 25
1.31×
0.91×
Q1 25
1.35×
Q4 24
2.78×
Q3 24
1.12×
-0.66×
Q2 24
1.90×
7.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons